Author

Julie Coussirou

Institution: Institut Sainte Catherine

Observed institutions: Assistance Publique Hôpitaux de Marseille, Hôpital de la Conception, Institut Sainte Catherine

ORCID: 0009-0009-7072-5860

Observed ORCID: 0009-0009-7072-5860

OpenAlex ID: A5077826445

Intradermal injection of a Tat Oyi-based therapeutic HIV vaccine reduces of 1.5 log copies/mL the HIV RNA rebound median and no HIV DNA rebound following cART interruption in a phase I/II randomized controlled clinical trial

2016 · Erwann P. Loret, Albert Darque, et al. · Retrovirology · 28

Erratum to: Intradermal injection of a Tat Oyi-based therapeutic HIV vaccine reduces of 1.5 log copies/mL the HIV RNA rebound median and no HIV DNA rebound following cART interruption in a phase I/II randomized controlled clinical trial

2016 · Erwann P. Loret, Albert Darque, et al. · Retrovirology · 5

Identification of factors associated with aggressive end-of-life antitumour treatment: retrospective study of 1282 patients with cancer

2020 · Philippe Debourdeau, Mohamed Belkacémi, et al. · BMJ Supportive & Palliative Care · 2

Case Report: Targeted interleukin-6 blockade by siltuximab for cytokine release syndrome control and infection limitation in thirteen patients treated with bi-specific T-cell engagers

2026 · Jean-François Rossi, Thierry Cailleux, et al. · Frontiers in Immunology · 1

Anti-Cancer Drug-Induced Lyell’s Syndrome: A Series of Two Patients

2024 · Julie Coussirou, Magali Ravoire, et al. · Current Oncology · 1

Palbociclib in Combination with Endocrine Therapy in Patients with Metastatic Breast Cancer in a Real-World Population: Impact of Dose-Intensity, Dose Reductions and Cycle Delays on Efficacy

2026 · Julie Coussirou, Julien Grenier, et al. · Current Oncology

Évaluation des besoins pour la mise en place d’une Unité de Thérapie Orale

2022 · Léa Vazquez, Julie Coussirou, et al. · Bulletin du Cancer

Intradermal injection of a Tat Oyi-based therapeutic HIV vaccine significantly reduces levels of HIV RNA and HIV DNA rebound following ART interruption in a phase I/II randomized controlled clinical trial

2016 · Erwann P. Loret, Albert Darque, et al. · Journal of Virus Eradication

Works count: 8

Citation count: 37

H-index: 2

I10-index: 1